Among the other cases, four out of ten patients in the mRNA vaccine group and one out of four patients in the viral vector group had a high CRP level of 100 mg/L or higher, suggesting that the mRNA group may be more likely to have GCA with a high inflammatory level. The gene discussed is CRP; the disease is temporal arteritis.